Literature DB >> 30982028

oXiris® Use in Septic Shock: Experience of Two French Centres.

Victor Schwindenhammer1, Thibaut Girardot2,3, Kevin Chaulier4, Arnaud Grégoire1, Céline Monard1, Laetitia Huriaux1, Julien Illinger4, Véronique Leray1, Thomas Uberti1, Jullien Crozon-Clauzel1, Thomas Rimmelé1,5.   

Abstract

BACKGROUND: Sepsis is a dysregulated host response to an infection and can result in organ dysfunctions and death. Extracorporeal blood purification techniques aim to improve the prognosis of these patients by modulating the unbalanced immune response. This study reports our experience with the use of the oXiris® membrane for septic shock patients requiring continuous renal replacement therapy (CRRT).
SUMMARY: Thirty-one patients were diagnosed with septic shock and underwent CRRT with the oXiris® membrane between 2014 and 2019. We compared the observed hospital mortality with that predicted by the Simplified Acute Physiology Score II (SAPS II). Change in the Sequential Organ Failure Assessment (SOFA) score and of the main clinical and biological parameters over time were analyzed. Hospital mortality was lower than predicted for the most severe patients (60 vs. 91% for the [74-87] SAPS II quartile and 70 vs. 98% for the [87-163] SAPS II quartile, p < 0.02). There was no significant improvement in the SOFA score from 0h to 48 h. An 88% relative decrease in norepinephrine infusion was observed (median at 0 h was 1.69 [0.52-2.45] µg/kg/min; at 48 h it was 0.20 [0.09-1.14] µg/kg/min, p = 0.002). Lactataemia and pH were significantly improved over time. Patients with intra-abdominal sepsis as well as those with Gram-negative bacilli (GNB) infections seemed to benefit the most from the therapy. Key Messages: CRRT with the oXiris® haemofilter resulted in higher observed survival than predicted by a severity score (SAPS II) for the most severe patients. Haemodynamic status and lactataemia appeared to improve, especially in intra-abdominal sepsis and GNB infections.
© 2019 The Author(s). Published by S. Karger AG, Basel.

Entities:  

Keywords:  Blood purification; Haemoadsorption; Renal replacement therapy; Sepsis; Septic shock; oXiris®

Mesh:

Year:  2019        PMID: 30982028     DOI: 10.1159/000499510

Source DB:  PubMed          Journal:  Blood Purif        ISSN: 0253-5068            Impact factor:   2.614


  17 in total

Review 1.  Current practice and evolving concepts in septic shock resuscitation.

Authors:  Jan Bakker; Eduardo Kattan; Djillali Annane; Ricardo Castro; Maurizio Cecconi; Daniel De Backer; Arnaldo Dubin; Laura Evans; Michelle Ng Gong; Olfa Hamzaoui; Can Ince; Bruno Levy; Xavier Monnet; Gustavo A Ospina Tascón; Marlies Ostermann; Michael R Pinsky; James A Russell; Bernd Saugel; Thomas W L Scheeren; Jean-Louis Teboul; Antoine Vieillard Baron; Jean-Louis Vincent; Fernando G Zampieri; Glenn Hernandez
Journal:  Intensive Care Med       Date:  2021-12-15       Impact factor: 17.440

Review 2.  Signaling pathways and intervention therapies in sepsis.

Authors:  Yun-Yu Zhang; Bo-Tao Ning
Journal:  Signal Transduct Target Ther       Date:  2021-11-25

Review 3.  New Decade, Old Debate: Blocking the Cytokine Pathways in Infection-Induced Cytokine Cascade.

Authors:  Mahrukh S Rizvi; Alice Gallo De Moraes
Journal:  Crit Care Explor       Date:  2021-03-23

Review 4.  Is there a role for blood purification therapies targeting cytokine storm syndrome in critically severe COVID-19 patients?

Authors:  Gang Chen; Yangzhong Zhou; Jie Ma; Peng Xia; Yan Qin; Xuemei Li
Journal:  Ren Fail       Date:  2020-11       Impact factor: 2.606

5.  Plasmapheresis reduces cytokine and immune cell levels in COVID-19 patients with acute respiratory distress syndrome (ARDS).

Authors:  Seyed MohammadReza Hashemian; Navid Shafigh; Golnaz Afzal; Hamidreza Jamaati; Payam Tabarsi; Majid Marjani; Majid Malekmohammad; Seyed Mehdi Mortazavi; Batoul Khoundabi; Davood Mansouri; Afshin Moniri; Abbas Hajifathali; Elham Roshandel; Esmaeil Mortaz; Ian M Adcock
Journal:  Pulmonology       Date:  2020-12-04

6.  Analysis of the dynamic relationship between immune profiles and the clinical features of patients with COVID-19.

Authors:  Pingping Ren; Chaohong Zhu; Yongchun He; Hong Jiang; Jianghua Chen
Journal:  Ann Transl Med       Date:  2021-07

7.  Cytokine Hemoadsorption as Rescue Therapy for Critically Ill Patients With SARS-CoV-2 Pneumonia With Severe Respiratory Failure and Hypercytokinemia.

Authors:  Juan Carlos Ruiz-Rodríguez; Luis Chiscano-Camón; Adolf Ruiz-Sanmartin; Clara Palmada; Erika Paola Plata-Menchaca; Clara Franco-Jarava; Marcos Pérez-Carrasco; Manuel Hernández-González; Ricard Ferrer
Journal:  Front Med (Lausanne)       Date:  2022-01-10

8.  Blood purification could tackle COVID-19?

Authors:  Hiroyuki Yamada; Shigeru Ohtsuru
Journal:  J Intensive Care       Date:  2021-12-11

9.  Potential effect of blood purification therapy in reducing cytokine storm as a late complication of critically ill COVID-19.

Authors:  Jie Ma; Peng Xia; Yangzhong Zhou; Zhengyin Liu; Xiang Zhou; Jinglan Wang; Taisheng Li; Xiaowei Yan; Limeng Chen; Shuyang Zhang; Yan Qin; Xuemei Li
Journal:  Clin Immunol       Date:  2020-04-01       Impact factor: 3.969

10.  The absorbing filter Oxiris in severe coronavirus disease 2019 patients: A case series.

Authors:  Hongtao Zhang; Guizhen Zhu; Lei Yan; Yang Lu; Qiying Fang; Fengmin Shao
Journal:  Artif Organs       Date:  2020-09-01       Impact factor: 2.663

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.